Description: Taj Pharmaceuticals Ltd is well recognized Manufacturer, Exporter and Supplier of Hydroxycarbamide Tablets from Vapi, Gujarat India. Routine monitoring is important to check your blood counts and ensure the medicine is working safely. Make sure to attend regular blood test appointments. Taj Pharmaceuticals Ltd, based in Vapi, Gujarat, India, is a renowned manufacturer, exporter, and supplier of Hydroxycarbamide (Hydroxyurea) Tablets 500mg, marketed under the brand name THAROLAX. The company is globally recognized for delivering premium-quality, WHO-GMP certified Hydroxycarbamide Tablets widely used in the treatment of head and neck cancers, chronic myeloid leukaemia (CML), and sickle cell disease. Hydroxycarbamide (Hydroxyurea) works by blocking the ribonucleotide reductase enzyme, stopping DNA synthesis in cancer cells, and increasing fetal hemoglobin (HbF) levels in sickle cell patients, improving red blood cell flexibility and reducing painful episodes. Taj Pharma ensures every batch meets the highest standards of purity, potency, and safety, supported by cutting-edge R&D and strict quality control systems. With a strong global footprint across India, Africa, the Middle East, and Latin America, Taj Pharmaceuticals provides bulk manufacturing, contract production, private labeling, and PCD Pharma Franchise services. Known for innovation, reliability, and compliance with international standards, Taj Pharma remains the top Hydroxyurea Tablets manufacturer in India. Taj Pharma India is well known Manufacturer, Exporter and Supplier of Hydroxycarbamide (Hydroxyurea) Tablets from Vapi, Gujarat India. In cancer, Hydroxyurea inhibits the enzyme ribonucleotide reductase, which plays a critical role in the synthesis of DNA by converting ribonucleotides into deoxyribonucleotides. This inhibition disrupts DNA synthesis, particularly in rapidly dividing cancer cells, resulting in cell cycle arrest and reduced tumor proliferation. In sickle cell disease, hydroxyurea increases the production of fetal hemoglobin (HbF) in red blood cells. Higher levels of HbF reduce the formation of sickled cells, improve red blood cell flexibility, enhance blood flow, and decrease the frequency of painful vaso-occlusive episodes and related complications.
Dimensions: 2560 x 1719
File Type: jpeg
File Size: 223 KB
